The role of novel prognostic factors in treatment of patient witn spine metastases
It performed the analysis of literature data on assessing cancer prognosis possibilities in patients with spine metastases. Surgical intervention for metastatic spinal lesions is palliative, but the majority of patients who undergo local treatment of a given volume in combination with systemic therapy, have improved their quality of life. It is noted that the adequate determination and use of prognostic factors in clinical practice in the planning of surgical treatment helps to determine spinal surgery volume and assess the life expectancy in this patients. It described the developed prognosis systems (Tokuhashi, Sioutos, Tomita, Van der Linden, Bauer), and it is indicated that these scales differ depending on the parameters included in them and do not take into account the options for systemic treatment of a malignant disease and the presence of mutations in the tumor. It was concluded that the treatment of spinal metastases should be individualized and multidisciplinary, the rational choice of treatment and its scope should be based on a comprehensive assessment of anamnestic, clinical and prognostic data. Accurate assessment of the postoperative survival prognosis will improve the quality of medical care for this category of patients and achieve optimal indicators of quality of life.